the fy13 ph/tbi research program tbi endpoints development (ted) award mechanism supports the establishment of a collaborative, multidisciplinary research team to advance endpoints for use in trials involving diagnosis and treatment of mild to moderate tbi (mtbi to modtbi). while a number of potentially useful endpoints for mtbi to modtbi diagnostics and therapeutics exist, a majority of them have not been validated and qualified for use as a reference measure of diagnostic or therapeutic effectiveness. the ted research team will address a critical need within the tbi research community by developing clinically relevant endpoints that can support regulatory approvals and be applicable for use in research tests and clinical trials.

the institute of cancer research (icr) in partnership with the national cancer institute of the nih and genome bc are pleased to announce the launch of a new funding opportunity to enable canadian participation in the quantitative imaging network (qin) established by the national cancer institute (nci) of the national institutes of health (nih).  this partnership between us and canadian researchers will promote research on quantitative imaging for prediction and measurement of tumour response to cancer therapies in clinical trial settings, with the overall goal of facilitating clinical decision making and personalized medicine approaches.

the nci has already established a quantitative imaging network (qin) that currently has 17 research teams across the us that share ideas and approaches to validate and standardize imaging data and related imaging metadata for quantitative measurements of responses to cancer therapies. the goal of this current initiative is enable the canadian cancer imaging research community to establish up to two canadian teams as an integral part of qin.

the fy14 dmrdp crmrp regenerative medicine clinical trial award (rmcta) is intended to support phase i or ii clinical trials focused on extremity regeneration, craniomaxillofacial regeneration, vascularized composite allografts, and/or genitourinary/lower abdomen reconstruction. funding from this award mechanism cannot be used for preclinical research studies. all clinical trials must be responsive to the health care needs of military service members and veterans, and all applications must specifically and clearly address the military relevance of the proposed research; however, the use of military populations in the proposed clinical trial(s) is not a requirement.

the fy13 dmrdp crmrp neurosensory research award (nsra) is intended to support both applied (preclinical) research and clinical trials within specific focus areas of pain management, hearing loss/dysfunction, balance disorders, and/or tinnitus. applications focused on traumatic brain injury (tbi) are highly encouraged.

the fy14 dmrdp crmrp neuromusculoskeletal injuries research award (nmsira) supports preclinical research and clinical trials on the functional utility of assistive devices related to the human-device interface, secondary health effects following severe extremity injury, and optimizing rehabilitation and device prescription for patients with severe extremity trauma.

available funding under this program

• neurosensory research award
• hypothesis development award
• translational research award

calling for proposals to compile research syntheses targeted broadly at three areas of healthcare delivery in northern, rural or remote settings:

    -models of primary healthcare delivery;

    -translating health policy into practice; and

    -inclusion of mental health and addictions services in interprofessional primary healthcare delivery.

- see more at: http://www.cfhi-fcass.ca/whatwedo/collaborations/northernruralremote.asp...

the postdoctoral enrichment program (pdep) provides a total of $50,000 over three years to support the career development activities for underrepresented minority postdoctoral fellows in a degree-granting institution (or its affiliated graduate and medical schools, hospitals and research institutions) in the united states or canada whose training and professional development are guided by mentors committed to helping them advance to stellar careers in biomedical or medical research. bwf is committed to funding the next generation of scientists and researchers, thus we have an interest in advancing the careers of underrepresented minority postdoctoral fellows.  up to 10 awards will be granted for enrichment activities annually. this grant is meant to supplement the training of postdocs whose research activities are already supported. it is not a research grant.